When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRTX - Mirati Therapeutics teams up with Boehringer Ingelheim in cancer study
Mirati Therapeutics Inc.
Germany-based Boehringer Ingelheim will collaborate with Mirati Therapeutics (NASDAQ:MRTX) on a clinical trial evaluating the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independent of mutation type, and the latter's MRTX849, a KRAS G12C selective inhibitor, in patients with solid tumors harboring the KRAS G12C mutation.
More news on: Mirati Therapeutics, Inc., Healthcare stocks news,